You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Vectura Limited v. GlaxoSmithKline LLC (D. Del. 2016)

✉ Email this page to a colleague

« Back to Dashboard

Vectura Limited v. GlaxoSmithKline LLC (D. Del. 2016)

Docket	⤷ Sign Up	Date Filed	2016-07-27
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	Both	Referred To
Patents	8,303,991; 8,435,567; 8,956,661
Link to Docket	External link to docket

Small Molecule Drugs cited in Vectura Limited v. GlaxoSmithKline LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Vectura Limited v. GlaxoSmithKline LLC (D. Del. 2016)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2018-10-01	167		of multiple terms in U.S. Patent Nos. 8,303 ,991 ("the ' 991 patent") and 8,435,567 ("…construction for multiple terms in U.S. Patent Nos. 8,303,991 and 8,435,567. Within five days the parties… '661 patent, which shares a specification with the '991 patent. (' 661 patent, claim 1).… an unrelated Vectura patent, Patent No. 9,351 ,928 ("the ' 928 patent"). During prosecution…construction disputes for U.S. Patent No. 8,956,661 ("the ' 661 patent"). (D.I. 82 at 1 n.1)	External link to document
2019-03-26	272	Opinion - Memorandum Opinion	infringement of U.S. Patent Nos. 8,303 ,991 ("the '991 patent") and 8,435,567 ("the '…Plaintiffs patents and patent applications ("the Non-Assert Patents"), including the patents-in-suit…; 991 patent and claim 3 of the ' 567 patent ("the Asserted Claims"). The patents-in- suit…or sells any patented invention within the United States ... during the term of the patent therefor, infringes…infringes the patent." (emphasis added). As defined by § 271(a), the practice of a patented invention	External link to document
2019-04-01	276	Order - -Memorandum and Order	U.S . Patent No. 8,303 ,991 ("the 991 patent") and claim 3 of U.S . Patent No. 8,435,567 ("…#39;567 patent") (collectively, "the Asserted Claims"). (D.I. 1). The patents-in-suit …for inhalation, and in the case of the ' 567 patent, delays dissolution of the active material. (See… 27 July 2016 1:16-cv-00638-RGA Patent Both District Court, D. Delaware	External link to document
2016-07-27	3		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,303,991. (nmb) (Entered: 07… 27 July 2016 1:16-cv-00638-RGA Patent Both District Court, D. Delaware	External link to document
2016-08-12	6		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,435,567; . (Farnan, Kelly) … 27 July 2016 1:16-cv-00638-RGA Patent Both District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.